Why consider treatment in China for Aortic Valve Stenosis?

China offers world-class expertise in transcatheter aortic valve replacement (TAVR/TAVI) at leading hospitals like Fuwai, Zhongshan, and Anzhen, which perform hundreds of procedures annually with outcomes comparable to top Western centers. The domestic Venus-A valve provides a clinically proven alternative to Edwards and Medtronic valves at roughly half the cost, making treatment significantly more affordable. Additionally, Chinese cardiologists have extensive experience with complex cases, including bicuspid valves and small anatomies, ensuring high-quality care.